We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+2.37%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.8B
AUM Growth
+$988M
(+10%)
Cap. Flow
+$812M
Cap. Flow
% of AUM
7.54%
Top 10 Holdings %
Top 10 Hldgs %
14.36%
Holding
2,596
New
200
Increased
685
Reduced
635
Closed
273
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$32.7M |
| 2 |
Eli Lilly
LLY
|
+$31M |
| 3 |
La-Z-Boy
LZB
|
+$17.4M |
| 4 |
Ubiquiti
UI
|
+$17.1M |
| 5 |
TriMas Corp
TRS
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LSB Industries
LXU
|
+$14M |
| 2 |
K
Kellanova
K
|
+$13.7M |
| 3 |
Apple
AAPL
|
+$13.1M |
| 4 |
Prosperity Bancshares
PB
|
+$11.7M |
| 5 |
Fluor
FLR
|
+$11.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.72% |
| 2 | Industrials | 12.7% |
| 3 | Healthcare | 12.22% |
| 4 | Financials | 10.93% |
| 5 | Energy | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Comcast
CMCSA
$79.1B
| $22.7M | 0.21% |
907,466
+3,932
| +0.4% | +$102K |
|
102
Bristol-Myers Squibb
BMY
$127B
| $22.7M | 0.21% |
436,119
-13,637
| -3% | -$726K |
|
103
Thor Industries
THO
$3.99B
| $22.6M | 0.21% |
369,982
+61,151
| +20% | +$3.4M |
|
|
CELG
104
DELISTED
Celgene Corp
CELG
| $22.2M | 0.21% |
318,250
+60,178
| +23% | +$4.77M |
|
|
ORB
105
DELISTED
ORBITAL SCIENCES CORP
ORB
| $22.2M | 0.21% |
795,095
+143,700
| +22% | +$3.79M |
|
106
Amphenol
APH
$188B
| $22M | 0.2% |
1,919,760
-43,872
| -2% | -$489K |
|
107
iShares Core S&P 500 ETF
IVV
$876B
| $21.8M | 0.2% |
115,608
+14,465
| +14% | +$2.67M |
|
108
Maximus
MMS
$3.14B
| $21.6M | 0.2% |
481,527
+86,642
| +22% | +$3.92M |
|
109
Coca-Cola Europacific Partners
CCEP
$46.5B
| $21.6M | 0.2% |
451,547
+147,458
| +48% | +$6.72M |
|
110
Northern Trust
NTRS
$22.2B
| $21.1M | 0.2% |
321,596
+20,734
| +7% | +$1.29M |
|
|
SAVE
111
DELISTED
Spirit Airlines, Inc.
SAVE
| $20.9M | 0.19% |
351,762
+61,676
| +21% | +$3.24M |
|
112
Wintrust Financial
WTFC
$10.7B
| $20.8M | 0.19% |
428,071
+70,846
| +20% | +$3.26M |
|
|
TWX
113
DELISTED
Time Warner Inc
TWX
| $20.7M | 0.19% |
330,757
+12,511
| +4% | +$785K |
|
114
Air Products & Chemicals
APD
$66.3B
| $20.6M | 0.19% |
186,984
+2,723
| +1% | +$289K |
|
115
Truist Financial
TFC
$63.2B
| $20.6M | 0.19% |
511,762
+301,093
| +143% | +$11.5M |
|
116
Littelfuse
LFUS
$10.2B
| $20.5M | 0.19% |
218,692
+36,229
| +20% | +$3.34M |
|
|
AFSI
117
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $20.3M | 0.19% |
1,080,530
+339,956
| +46% | +$5.96M |
|
118
Graphic Packaging
GPK
$3.26B
| $20.3M | 0.19% |
1,996,354
+329,949
| +20% | +$3.26M |
|
|
CATM
119
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $20.1M | 0.19% |
517,554
+85,159
| +20% | +$3.45M |
|
|
EFII
120
DELISTED
Electronics for Imaging
EFII
| $20M | 0.19% |
462,283
+1,297
| +0.3% | +$54.7K |
|
121
Occidental Petroleum
OXY
$57B
| $20M | 0.19% |
218,978
+60,876
| +39% | +$5.44M |
|
122
Northrop Grumman
NOC
$77B
| $19.7M | 0.18% |
159,934
-21,359
| -12% | -$2.53M |
|
123
BorgWarner
BWA
$13.2B
| $19.6M | 0.18% |
362,584
+3,017
| +0.8% | +$154K |
|
|
AEL
124
DELISTED
American Equity Investment Life Holding Company
AEL
| $19.6M | 0.18% |
827,967
+138,183
| +20% | +$3.19M |
|
125
Texas Instruments
TXN
$255B
| $19.4M | 0.18% |
411,877
+12,875
| +3% | +$568K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2014 Portfolio in Review
As of Q1 2014, Glenmede Trust held 2,596 positions worth $10.8B, up 10% from $9.79B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Glenmede Trust deployed $812M of net new capital in Q1 2014, opening 200 new positions and adding to 685 existing holdings. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Kellanova, an estimated $13.7M trimmed.
- Glenmede Trust's largest Q1 2014 buy was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.
- Glenmede Trust added most to Eli Lilly in Q1 2014, an estimated $31M increase.
- Glenmede Trust's biggest Q1 2014 reduction was Kellanova, cutting an estimated $13.7M.
- Glenmede Trust fully exited LSB Industries in Q1 2014, selling an estimated $14M.
- Glenmede Trust's ten largest holdings make up 14% of its $10.8B portfolio in Q1 2014.
- Glenmede Trust opened 200 new positions and closed 273 in Q1 2014.
- Glenmede Trust's portfolio value rose 10% quarter-over-quarter to $10.8B.
Based on Glenmede Trust's 13F filing for Q1 2014, filed 7 May 2014.